Fidelity Management & Research Co.. has recently announced that it has increased stake in Amyris Inc. (NASDAQ:AMRS) by 9.41%. After grabbing 14.12 million shares, the institutional investor is now in possession of 1.21 million shares of the Basic Materials Company. The new investment brought the stake of investor firm to 6.90% having worth around $60.45 million. Moreover, Farallon Capital Management LLC increased its share by 7.01 million to have a control over 7.01 million shares. And BlackRock Fund Advisors raised its holdings to 2.0 million shares by acquiring 6.21 million shares or 3.04% of the stake.

Amyris Inc. (AMRS) concluded trading on 08/27/20 at a closing price of $3.19, with 2.33 million shares of worth about $7.45 million changed hands on the day. Weekly performance of the stock remained negative as price took a plunge of -7.80% during that period and on Thursday the price saw a loss of about -1.24%. Currently the company’s common shares owned by public are about 184.83M shares, out of which, 116.10M shares are available for trading.

A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 2 analysts are covering the AMRS stock and their offered price forecasts bring an average price target of $10.00. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $11.00 and could fall to a lowest price of $9.00. Analysts also issued an outlook of 1.50 for the Amyris Inc. stock for next 12 months. However, touching the estimated high of $11.00 would mean a gain of 71.0% for the stock.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 50 times over the past 12 months. They bought 40,412,972 shares in 37 of the transactions. In 13 selling transactions, insiders dumped 314,242 shares.

Fidelity Balanced Fund, Fidelity Strategic Advisers US To, and Victory RS Small Cap Growth Fund are the top 3 mutual funds which are holding stakes in Amyris Inc. Fidelity Balanced Fund is currently holding 9.9 million shares of worth totaling $42.35 million. The company recently came buying 0.1 million shares which brought its stake up to 4.84% of the company’s outstanding shares. Fidelity Strategic Advisers US To bought 38810.0 shares, after which its hold over company’s outstanding shares expand to 1.18%, leaving 2.41 million shares with the mutual fund that have a worth of about $10.34 million. Victory RS Small Cap Growth Fund, after buying 2.25 million shares, have now control over 1.10% of the stake in the company. It holds 2.25 million shares of worth $9.62 million.

Amyris Inc. (NASDAQ: AMRS) started trading at $3.23, below $0.0 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $3.19, or with a loss of -1.24%. Stock saw a price change of -7.80% in past 5 days and over the past one month there was a price change of -26.50%. Year-to-date (YTD), AMRS shares are showing a performance of 3.24% which decreased to -13.08% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.40 but also hit the highest price of $6.07 during that period. While comparing its average daily trading volume of 2.70 million shares, we see that about 2.33 million changed hands on the day. The stock is currently trading -16.36% below its 20-day simple moving average (SMA20), while that difference is down -22.31% for SMA50 and it goes to -6.14% lower than SMA200.

Fidelity Management & Research Co.. acquired 14.12 million shares of Amyris Inc. having value of about $60.45 million. Data submitted at the U.S SEC by Fidelity Management & Research Co.. revealed that the firm now holds 1.21 million shares in the company valued at close to $3873473.45, or have control over 9.41% stake in the company. Amyris Inc. (NASDAQ: AMRS) currently have 184.83M outstanding shares and institutions hold larger chunk of about 42.40% of that. Holding of mutual funds in the company is about 17.24% while other institutional holders and individual stake holders have control over 50.54% and 15.68% of the stake respectively.

The stock has a current market capitalization of $666.61M and its 3Y-monthly beta is at 0.56. It has posted earnings per share of -$2.20 in the same period. It has Quick Ratio of 1.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AMRS, volatility over the week remained 6.06% while standing at 7.69% over the month.

Analysts are in expectations that Amyris Inc. (AMRS) stock would likely to be making an EPS of -$0.17 in the current quarter, while forecast for next quarter ESPS is -$0.05 and it is -$0.32 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.2 which is -$0.14 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.51 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 27.80% while it is estimated to increase by 74.00% in next year. EPS is likely to grow at an annualized rate of 30.00% for next 5-years, compared to annual growth of -51.90% made by the stock over the past 5-years.

Analysts at 2 brokerage firms have issued recommendations for the Amyris Inc. (AMRS)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.50. Out of those 2 Wall Street analysts, 2 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Oppenheimer on December 12, 2019 offering an Outperform rating for the stock and assigned a target price of $8 to it. Coverage by B. Riley FBR stated Amyris Inc. (AMRS) stock as a Buy in their note to investors on November 14, 2018, suggesting a price target of $8 for the stock. On January 25, 2018, B. Riley FBR Inc. Initiated their recommendations, while on May 28, 2014, Stifel Resumed their ratings for the stock with a price target of. Stock get a Hold rating from Deutsche Bank on February 10, 2012.